EORTC-22791-ROG

Phase III trial of twice daily fractions versus single daily fraction radiotherapy in oropharyngeal carcinoma
Trial StatusAll trial activities ended
DatesDate of activation: 15-Feb-80
Closed on : 15-Apr-87
Data management at EORTCFull
Phase3
Randomized trial
Type-
Targeted Sample size300
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryClinicalTrials.gov
NCT number
EudraCT